OpGen Investor Relations Material
Latest events
Q2 2023
OpGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from OpGen Inc
Access all reports
OpGen, Inc. is a precision medicine company that focuses on developing molecular diagnostic tools for the detection of infectious diseases. The company's products and services include rapid diagnostic tests and bioinformatics solutions designed to identify bacterial pathogens and antibiotic resistance. OpGen serves healthcare providers and laboratories, aiming to improve patient outcomes through faster, more accurate diagnostics for conditions such as urinary tract infections and bloodstream infections. The company is headquartered in Rockville, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
OPGN
Country
🇺🇸 United States